Pursuant to the Regulation 29 and other applicable Regulation(s) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Bharat Immunologicals & Biologicals Corporation has informed that a meeting of the Board of Directors of the Company is scheduled to be held on Friday, 08 March 2024 for General Purpose.
The above information is a part of company’s filings submitted to BSE.